Thursday - April 17, 2025

Vanda Pharmaceuticals Assigned Patent

2016-10-06

ALEXANDRIA, Va., Oct. 6 -- Vanda Pharmaceuticals, Washington, has been assigned a patent (9,458,507) developed by four co-inventors for the "antipsychotic treatment based on SNP genotype." The co-inventors are Christian Lavedan, Potomac, Maryland, Simona Volpi, Derwood, Maryland, Louis Licamele, Potomac, Maryland, and Mihael H. Polymeropoulos, Potomac, Maryland.

The patent application was filed on March 30, 2016 (15/085,778). The full-text of the patent can be found at http://patf . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Vanda Pharmaceuticals Assigned Patent

Information Request Form

Copyright Targeted News Service 2016